δ-opioid receptor activation protects against Parkinson's disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy.

Aging
Yuan XuYing Xia

Abstract

Our previous studies have shown that the δ-opioid receptor (DOR) is an important neuroprotector via the regulation of PTEN-induced kinase 1 (PINK1), a mitochondria-related molecule, under hypoxic and MPP+ insults. Since mitochondrial dysfunctions are observed in both hypoxia and MPP+ insults, this study further investigated whether DOR is cytoprotective against these insults by targeting mitochondria. Through comparing DOR-induced responses to hypoxia versus MPP+-induced parkinsonian insult in PC12 cells, we found that both hypoxia and MPP+ caused a collapse of mitochondrial membrane potential and severe mitochondrial dysfunction. In sharp contrast to its inappreciable effect on mitochondria in hypoxic conditions, DOR activation with UFP-512, a specific agonist, significantly attenuated the MPP+-induced mitochondrial injury. Mechanistically, DOR activation effectively upregulated PINK1 expression and promoted Parkin's mitochondrial translocation and modification, thus enhancing the PINK1-Parkin mediated mitophagy. Either PINK1 knockdown or DOR knockdown largely interfered with the DOR-mediated mitoprotection in MPP+ conditions. Moreover, there was a major difference between hypoxia versus MPP+ in terms of the regulation of mito...Continue Reading

References

Jun 3, 1989·Lancet·A H SchapiraC D Marsden
Jan 10, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P H Chan
Apr 30, 2003·The Journal of Biological Chemistry·Julie L WebbDavid C Rubinsztein
Jul 5, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yufeng YangBingwei Lu
Aug 16, 2006·Trends in Pharmacological Sciences·Pershia SamadiClaude Rouillard
Jun 12, 2010·Annals of the New York Academy of Sciences·Stephen M Johnson, Sara M F Turner
Dec 1, 2010·The Journal of Cell Biology·Seok Min JinRichard J Youle
Apr 12, 2012·Expert Reviews in Molecular Medicine·Cristina M CostantinoLakshmi A Devi
Jun 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jonathon L BurmanLeo Pallanck
Mar 5, 2013·Current Opinion in Neurobiology·Pierre-Eric Lutz, Brigitte L Kieffer
Jul 16, 2013·Methods in Enzymology·Mirella TrineiMarco Giorgio
Jan 16, 2014·Journal of Neuropathology and Experimental Neurology·Anne-Sophie Van RompuyVeerle Baekelandt
Jun 7, 2014·Cell Research·Lei LiuKoji Okamoto
Jul 6, 2014·Molecular Neurobiology·H ZhangH Yang
Jul 24, 2014·British Journal of Pharmacology·Jianfeng LiangYing Xia
Sep 18, 2014·CNS Neuroscience & Therapeutics·Ruo-Yang ShiJi-Ming Kong
Jan 23, 2015·Neuron·Alicia M Pickrell, Richard J Youle
Aug 13, 2015·Nature·Michael LazarouRichard J Youle
Nov 10, 2015·Molecular Cell·Nuo SunToren Finkel
Feb 4, 2016·Journal of Biochemistry·Noriyuki Matsuda
Jul 28, 2016·The FEBS Journal·Christina PloumiNektarios Tavernarakis
Aug 16, 2016·International Journal of Molecular Sciences·Yuan XuYing Xia
Aug 25, 2016·Protein & Cell·Yan-Cheng TangHu-Biao Chen
Feb 6, 2017·Journal of Cell Science·Kyle H Flippo, Stefan Strack
Feb 27, 2017·Neurochemistry International·Elayne M FivensonEvandro F Fang
Mar 25, 2017·Frontiers in Molecular Neuroscience·Marta Martinez-Vicente
Apr 13, 2017·Molecular Neurobiology·Anthony R AnzellThomas H Sanderson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
transfection
ubiquitination
ubiquitinations
flow cytometry
protein assay

Software Mentioned

GraphPad
GraphPad Prism
Image J
TMRM

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.